Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Krishnan H Harshan"'
Autor:
Nishant Ranjan Chauhan, Soumya Kundu, Ramyasingh Bal, Diya Chattopadhyay, Rinku Sahu, Subhash Mehto, Rina Yadav, Sivaram Krishna, Kautilya Kumar Jena, Sameekshya Satapathy, Anusha Pv, Krushna C. Murmu, Bharati Singh, Srinivas Patnaik, Sarita Jena, Krishnan H. Harshan, Gulam Hussain Syed, Mohammed M. Idris, Punit Prasad, Santosh Chauhan
Publikováno v:
Cell Reports, Vol 42, Iss 11, Pp 113275- (2023)
Summary: Type I interferon (IFN-I) response is the first line of host defense against invading viruses. In the absence of definite mouse models, the role of IFN-I in SARS-CoV-2 infection remains perplexing. Here, we develop two mouse models, one with
Externí odkaz:
https://doaj.org/article/e6915b55492c4d7ebdd1b0b0ae5b76e6
Autor:
Shuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, Dipanjali Sinha, Divya Gupta, Mercy Rophina, Paras Sehgal, Srikanth Sadhu, Manas Ranjan Tripathy, Sweety Samal, Souvik Maiti, Vinod Scaria, Sridhar Sivasubbu, Amit Awasthi, Krishnan H. Harshan, Sanjeev Jain, Shantanu Chowdhury
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
The COVID-19 pandemic caused by SARS-CoV-2 has caused millions of infections and deaths worldwide. Limited treatment options and the threat from emerging variants underline the need for novel and widely accessible therapeutics. G-quadruplexes (G4s) a
Externí odkaz:
https://doaj.org/article/be185dc57a37426ca40b3079c5373adf
Autor:
Dixit Tandel, Vishal Sah, Nitesh Kumar Singh, Poojitha Sai Potharaju, Divya Gupta, Sauhard Shrivastava, Divya Tej Sowpati, Krishnan H. Harshan
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT The Delta variant of SARS-CoV-2 has caused more severe infections than its previous variants. We studied the host innate immune response to Delta, Alpha, and two earlier variants to map the evolution of the recent ones. Our biochemical and t
Externí odkaz:
https://doaj.org/article/9cdc4c5afd8e4fd8b8564b3b81503be2
Autor:
Geetanjali Negi, Anurag Sharma, Monika Chaudhary, Divya Gupta, Krishnan H. Harshan, Nagma Parveen
Publikováno v:
ACS Infectious Diseases.
Autor:
Nishant Ranjan Chauhan, Soumya Kundu, Ramyasingh Bal, Diya Chattopadhyay, Subhash Mehto, Rinku Sahu, Rina Yadav, Sivaram Krishna, Kautilya Kumar Jena, Sameekshya Satapathy, Krushna C. Murmu, Bharati Singh, Saroj Kumar Das, Sarita Jena, Krishnan H. Harshan, Gulam Hussain Syed, Punit Prasad, Santosh Chauhan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc295fe57ad8a08f5d5370dffa909577
https://doi.org/10.2139/ssrn.4419228
https://doi.org/10.2139/ssrn.4419228
Autor:
Nishant Ranjan Chauhan, Soumya Kundu, Ramyasingh Bal, Diya Chattopadhyay, Subhash Mehto, Rinku Sahu, Rina Yadav, Sivaram Krishna, Kautilya Kumar Jena, Sameekshya Satapathy, Krushna C Murmu, Bharati Singh, Saroj Kumar Das, Sarita Jena, Krishnan H Harshan, Gulam Hussain Syed, Punit Prasad, Santosh Chauhan
Type 1 interferon (IFN-I) response is the first line of host defense against invading viruses. In the absence of definite mouse models, the role of IFN-I in SARS-CoV-2 infections remained to be perplexing. Here, we developed two mouse models, one wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0930f78853f2d252dd465f5c9500d92b
https://doi.org/10.1101/2022.12.17.520843
https://doi.org/10.1101/2022.12.17.520843
Autor:
Shuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, Dipanjali Sinha, Divya Gupta, Mercy Rophina, Paras Sehgal, Srikanth Sadhu, Manas Ranjan Tripathy, Sweety Samal, Souvik Maiti, Vinod Scaria, Sridhar Sivasubbu, Amit Awasthi, Krishnan H Harshan, Sanjeev Jain, Shantanu Chowdhury
The COVID-19 pandemic caused by SARS-CoV-2 has caused millions of infections and deaths worldwide. Limited treatment options and the threat from emerging variants underline the need for novel and widely accessible therapeutics. G-quadruplexes (G4s) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25b5c74906c7e0f0f8a4b0e51e754375
https://doi.org/10.1101/2022.05.31.493843
https://doi.org/10.1101/2022.05.31.493843
Autor:
Dixit Tandel, Vishal Sah, Nitesh Kumar Singh, Poojitha Sai Potharaju, Divya Gupta, Sauhard Shrivastava, Divya Tej Sowpati, Krishnan H Harshan
Delta variant of SARS-CoV-2 has caused more severe infections than its previous variants. We studied the host innate immune response to Delta, Alpha and two earlier variants to map the evolution of the recent ones. Our biochemical and transcriptomic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20e376aa2ab9e0732250c945f3f3b947
https://doi.org/10.1101/2022.02.22.481430
https://doi.org/10.1101/2022.02.22.481430
Autor:
Shivranjani C. Moharir, Sharath Chandra Thota, Arushi Goel, Bhuwaneshwar Thakur, Dixit Tandel, S. Mahesh Reddy, Amareshwar Vodapalli, Gurpreet Singh Bhalla, Dinesh Kumar, Digvijay Singh Naruka, Ashwani Kumar, Amit Tuli, Swathi Suravaram, Thrilok Chander Bingi, M. Srinivas, Rajarao Mesipogu, Krishna Reddy, Sanjeev Khosla, Krishnan H. Harshan, Karthik Bharadwaj Tallapaka, Rakesh K. Mishra
Publikováno v:
Journal of aerosol science. 164
To understand the transmission characteristics of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) through air, samples from different locations occupied by coronavirus disease (COVID-19) patients were analyzed. Three sampling strategies
Publikováno v:
Virus Research. 323:199010
People with diabetes are reported to have a higher risk of experiencing severe COVID-19 complications. Metformin, a first-line medication for type 2 diabetes, has antiviral properties. Some studies have indicated its prognostic potential in COVID-19.